Corynebacterium - Revision history

Aidan: /* Management */ typo

2025-02-24T18:18:20Z

Management: typo

← Older revision		Revision as of 18:18, 24 February 2025
Line 136:		Line 136:
	![[Trimethoprim-sulfamethoxazole\|SXT]]		![[Trimethoprim-sulfamethoxazole\|SXT]]
	![[Rifampin\|RIF]]		![[Rifampin\|RIF]]
	![[Quinupristin-dalfopristin\|Q-D		![[Quinupristin-dalfopristin\|Q-D]]
	![[Linezolid\|LZD]]		![[Linezolid\|LZD]]
	![[Gentamicin\|GEN]]		![[Gentamicin\|GEN]]

2025-02-24T18:17:55Z

Management

2024-11-14T02:15:48Z

← Older revision		Revision as of 02:15, 14 November 2024
Line 125:		Line 125:
	** See also [[CiteRef::neemuchwala2018in]] for a recent summary of susceptibilities in Ontario		** See also [[CiteRef::neemuchwala2018in]] for a recent summary of susceptibilities in Ontario
	{\| class="wikitable"		{\| class="wikitable"
	\|+Susceptibilities in Ontario 2011-2016[[CiteRef::neemuchwala2018]]		\|+Susceptibilities (in %) in Ontario 2011-2016[[CiteRef::neemuchwala2018]]
	!Species		!Species
	!PEN		!PEN

2024-11-14T02:15:19Z

2024-09-19T17:43:19Z

← Older revision		Revision as of 17:43, 19 September 2024
Line 123:		Line 123:
	* The only reliable treatment options are [[vancomycin]], [[daptomycin]], and [[linezolid]][[CiteRef::neemuchwala2018in]]		* The only reliable treatment options are [[vancomycin]], [[daptomycin]], and [[linezolid]][[CiteRef::neemuchwala2018in]]
	** [[Tetracycline]] and [[TMP-SMX]] are sometimes options depending on the species and isolate		** [[Tetracycline]] and [[TMP-SMX]] are sometimes options depending on the species and isolate
			** See also [[CiteRef::neemuchwala2018in]] for a recent summary of susceptibilities in Ontario
	** See also <ref name=":0">Neemuchwala A, Soares D, Ravirajan V, Marchand-Austin A, Kus JV, Patel SN. ''In Vitro'' Antibiotic Susceptibility Pattern of Non-diphtheriae Corynebacterium Isolates in Ontario, Canada, from 2011 to 2016. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e01776-17. doi: [https://doi.org/10.1128/aac.01776-17 10.1128/AAC.01776-17]. PMID: [https://pubmed.ncbi.nlm.nih.gov/29339389/ 29339389]; PMCID: [http://www.ncbi.nlm.nih.gov/pmc/articles/pmc5914010/ PMC5914010].</ref> for a recent summary of susceptibilities in Ontario

	{{DISPLAYTITLE:''Corynebacterium''}}		{{DISPLAYTITLE:''Corynebacterium''}}
	[[Category:Gram-positive bacilli]]		[[Category:Gram-positive bacilli]]

2023-09-27T14:38:30Z

Management

← Older revision		Revision as of 14:38, 27 September 2023
Line 123:		Line 123:
	* The only reliable treatment options are [[vancomycin]], [[daptomycin]], and [[linezolid]][[CiteRef::neemuchwala2018in]]		* The only reliable treatment options are [[vancomycin]], [[daptomycin]], and [[linezolid]][[CiteRef::neemuchwala2018in]]
	** [[Tetracycline]] and [[TMP-SMX]] are sometimes options depending on the species and isolate		** [[Tetracycline]] and [[TMP-SMX]] are sometimes options depending on the species and isolate
			** See also <ref name=":0">Neemuchwala A, Soares D, Ravirajan V, Marchand-Austin A, Kus JV, Patel SN. ''In Vitro'' Antibiotic Susceptibility Pattern of Non-diphtheriae Corynebacterium Isolates in Ontario, Canada, from 2011 to 2016. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e01776-17. doi: [https://doi.org/10.1128/aac.01776-17 10.1128/AAC.01776-17]. PMID: [https://pubmed.ncbi.nlm.nih.gov/29339389/ 29339389]; PMCID: [http://www.ncbi.nlm.nih.gov/pmc/articles/pmc5914010/ PMC5914010].</ref> for a recent summary of susceptibilities in Ontario
	{{DISPLAYTITLE:''Corynebacterium''}}		{{DISPLAYTITLE:''Corynebacterium''}}
	[[Category:Gram-positive bacilli]]		[[Category:Gram-positive bacilli]]

2022-01-25T16:46:34Z

Aidan moved page Corynebacterium species to Corynebacterium without leaving a redirect

← Older revision		Revision as of 16:46, 25 January 2022
(No difference)

2022-01-25T16:46:29Z

Text replacement - " species]]" to "]]"

← Older revision		Revision as of 16:46, 25 January 2022
Line 82:		Line 82:
	\|		\|
	\|-		\|-
	\|[[Brevibacterium ~~species~~]]		\|[[Brevibacterium]]
	\|nosocomial [[meningitis]], [[CAPD]] [[peritonitis]]		\|nosocomial [[meningitis]], [[CAPD]] [[peritonitis]]
	\|		\|
Line 90:		Line 90:
	\|		\|
	\|-		\|-
	\|[[Cellulosimicrobium ~~species~~]]		\|[[Cellulosimicrobium]]
	\|		\|
	\|		\|
	\|-		\|-
	\|[[Dermabacter ~~species~~]]		\|[[Dermabacter]]
	\|[[CAPD]] [[peritonitis]]		\|[[CAPD]] [[peritonitis]]
	\|		\|
	\|-		\|-
	\|[[Microbacterium ~~species~~]]		\|[[Microbacterium]]
	\|[[CLABSI]]		\|[[CLABSI]]
	\|		\|
	\|-		\|-
	\|[[Oerskovia ~~species~~]]		\|[[Oerskovia]]
	\|[[CLABSI]]		\|[[CLABSI]]
	\|		\|

2022-01-25T16:46:27Z

← Older revision		Revision as of 16:46, 25 January 2022
Line 123:		Line 123:
	* The only reliable treatment options are [[vancomycin]], [[daptomycin]], and [[linezolid]][[CiteRef::neemuchwala2018in]]		* The only reliable treatment options are [[vancomycin]], [[daptomycin]], and [[linezolid]][[CiteRef::neemuchwala2018in]]
	** [[Tetracycline]] and [[TMP-SMX]] are sometimes options depending on the species and isolate		** [[Tetracycline]] and [[TMP-SMX]] are sometimes options depending on the species and isolate
	{{DISPLAYTITLE:''Corynebacterium'' ~~species~~}}		{{DISPLAYTITLE:''Corynebacterium''}}
	[[Category:Gram-positive bacilli]]		[[Category:Gram-positive bacilli]]

2021-02-10T14:08:54Z

← Older revision		Revision as of 14:08, 10 February 2021
Line 118:		Line 118:
	\|		\|
	\|}		\|}

			== Management ==

			* The only reliable treatment options are [[vancomycin]], [[daptomycin]], and [[linezolid]][[CiteRef::neemuchwala2018in]]
			** [[Tetracycline]] and [[TMP-SMX]] are sometimes options depending on the species and isolate
	{{DISPLAYTITLE:''Corynebacterium'' species}}		{{DISPLAYTITLE:''Corynebacterium'' species}}
	[[Category:Gram-positive bacilli]]		[[Category:Gram-positive bacilli]]

← Older revision		Revision as of 18:18, 24 February 2025
Line 136:		Line 136:
	![[Trimethoprim-sulfamethoxazole\|SXT]]		![[Trimethoprim-sulfamethoxazole\|SXT]]
	![[Rifampin\|RIF]]		![[Rifampin\|RIF]]
	![[Quinupristin-dalfopristin\|Q-D		![[Quinupristin-dalfopristin\|Q-D]]
	![[Linezolid\|LZD]]		![[Linezolid\|LZD]]
	![[Gentamicin\|GEN]]		![[Gentamicin\|GEN]]